<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Extensive cutaneous <z:mp ids='MP_0001651'>necrosis</z:mp> (ECN) associated with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> is a rare presentation </plain></SENT>
<SENT sid="1" pm="."><plain>We describe 2 patients with ECN and high titers of anticardiolipin antibodies </plain></SENT>
<SENT sid="2" pm="."><plain>The mechanism by which these antibodies act has not been established and there is still controversy regarding treatment of these patients without established guidelines </plain></SENT>
<SENT sid="3" pm="."><plain>In the few documented cases the use of pulse steroid therapy, <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, fibrinolytic agents, plasmapheresis, or a combination of them has shown some benefit </plain></SENT>
<SENT sid="4" pm="."><plain>Early recognition and treatment of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> may limit the extent of thrombotic complications that can result in tissue <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
</text></document>